Cholinesterase inhibition remains a cornerstone of symptomatic therapy for Alzheimer’s disease, targeting the enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) to restore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results